The clinical study on gastrodin injection combined with routine treatment for patients with sudden hearing loss
Objective Observation of the clinical efficacy of gastrodin injection combined with routine treatment in patients with sudden hearing loss.Methods A retrospective analysis was conducted on the data of 117 sudden hearing loss patients admitted to a hospital from January 2022 to December 2022.They were divided into the control group(51 cases)and the observation group(66 cases)based on their therapeutic method.The control group received routine treatment in accordance with the 2015 China Guidelines for the Diagnosis and Treatment of Sudden Deafness;the observation group received intravenous drip of gastrodin injection on the basis of the control group.When the patients were admitted to hospital and treated after 10 days,the improvement of hearing,dizziness,and tinnitus scores were compared between the two groups.Results There was no sta-tistically difference in age,gender,and ear profile between the two groups(P>0.05).Both groups of patients showed improvement in hearing after treatment,and compared with the control group,the observation group had a better improvement,and there was statistical difference(t=4.698,P<0.05).The total effective rates of the control group and the observation group were respectively 72.5％and 89.4％,with a statistically significant difference(x2=5.543,P=0.019).The VAS scores of both groups were improved after treatment,and the observation group showed a better outcome in VAS scores,there was statistically significant difference(t=3.820,P<0.05).Both groups showed an improvement in TEQ scores after treatment also,but the observation group was more effective,there was statistical difference(t=7.238,P<0.05).Conclusion Gastrodin injection can improve the hearing of the sudden hearing loss patients,the clinical effect is exact,and can relieve the accompanying symptoms such as vertigo and tinnitus.
NETL
NSTL
万方数据
